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Summary
Mycobacterium tuberculosis (M.tb), which causes
tuberculosis, is a host-adapted intracellular
pathogen of macrophages. Intracellular pattern
recognition receptors in macrophages such as
nucleotide-binding oligomerization domain (NOD)
proteins regulate pro-inflammatory cytokine pro-
duction. NOD2-mediated signalling pathways in
response to M.tb have been studied primarily in
mouse models and cell lines but not in primary
human macrophages. Thus we sought to deter-
mine the role of NOD2 in regulating cytokine pro-
duction and growth of virulent M.tb and attenuated
Mycobacterium bovis BCG (BCG) in human mac-
rophages. We examined NOD2 expression during
monocyte differentiation and observed a marked
increase in NOD2 transcript and protein following
2–3 days in culture. Pre-treatment of human
monocyte-derived and alveolar macrophages with
the NOD2 ligand muramyl dipeptide enhanced pro-
duction of TNF-a and IL-1b in response to M.tb and
BCG in a RIP2-dependent fashion. The NOD2-
mediated cytokine response was significantly
reduced following knock-down of NOD2 expres-
sion by using small interfering RNA (siRNA) in
human macrophages. Finally, NOD2 controlled the
growth of both M.tb and BCG in human macro-
phages, whereas controlling only BCG growth
in murine macrophages. Together, our results
provide evidence that NOD2 is an important intra-
cellular receptor in regulating the host response to
M.tb and BCG infection in human macrophages.cmi_1544 402..418
Introduction
Tuberculosis (TB) is currently the leading cause of death
in HIV-infected persons (WHO, 2006). Multi-drug-resistant
Mycobacterium tuberculosis (M.tb) strains have limited
our ability to use the current antibiotic supply, and the
development of new antibiotics requires a better under-
standing of the biological mechanisms underlying M.tb
growth and survival within the host. Humans are the only
known natural host for M.tb and alveolar macrophages
(AMs) in the lung microenvironment are the first immune
cells that encounter inhaled mycobacteria (Fenton et al.,
2005). Thus, knowledge about pathogenic events for M.tb
in primary human macrophages is particularly important.
Macrophages are equipped with an array of defence
mechanisms to recognize and clear invading pathogens.
Several studies demonstrate that M.tb interacts with
macrophage membrane receptors such as the mannose
receptor (MR), complement receptors, Toll-like receptors
(TLR) and scavenger receptors (Fenton et al., 2005).
Engagement of specific receptor pathways during phago-
cytosis of mycobacteria regulates the early host response
through defined signalling pathways (Dao et al., 2004;
Kang et al., 2005; Torrelles et al., 2008). Among these are
the group of cytosolic receptors called nucleotide-binding
oligomerization domain (NOD)-like receptors (NLRs)
(Franchi et al., 2008) which function as intracellular
pattern recognition receptors (PRRs) that recognize
pathogens or pathogen secreted molecules (Ting et al.,
2010).
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cellular microbiology
There are 23 NLRs which can be divided into four
subfamilies depending on the composition of their
N-terminal effector domain. For example, those contain-
ing a caspase recruitment domain (CARD) as their effec-
tor domain are known as the NLRC subfamily and consist
of proteins that initiate a pro-inflammatory response by
signalling through their CARD domain. NOD2, a member
of this subfamily, is found in epithelial cells and antigen
presenting cells such as macrophages (Ogura et al.,
2001a; Gutierrez et al., 2002; Inohara and Nunez, 2003).
NOD2 regulates the production of inflammatory mediators
in response to muramyl dipeptide (MDP) which is found in
Gram-negative and Gram-positive bacteria and mycobac-
teria (Girardin et al., 2003; Coulombe et al., 2009). Many
studies have found that NOD2 is able to recognize and
generate a response to a variety of microorganisms (Opitz
et al., 2004; Ferwerda et al., 2005; Kobayashi et al., 2005;
Herskovits et al., 2007; Kapetanovic et al., 2007; Hsu
et al., 2008; Kim et al., 2008; Till et al., 2008; Deshmukh
et al., 2009; Hruz et al., 2009; Loving et al., 2009). NOD2
senses bacteria through its leucine-rich repeats (LRR),
then oligomerizes through its NOD domain and is able to
recruit receptor interacting protein 2 (RIP2) through an
electrostatic interaction of the CARD domain in each
protein. This leads to a signalling cascade in which acti-
vation and translocation of nuclear factor-kB (NF-kB) into
the nucleus occurs in order to transcribe pro-inflammatory
cytokines (Inohara and Nunez, 2003; Strober et al., 2006;
Abbott et al., 2007; Kufer, 2008; Hu et al., 2010).
Recent studies provide evidence that NOD2 is involved
in the host response and pathogenesis of mycobacterial
infections. For example, a genome analysis of patients with
leprosy found a single-nucleotide polymorphism in the
NOD2gene(Zhanget al.,2009)which is linked toMycobac-
terium leprae susceptibility. Furthermore,AfricanAmerican
patients with TB have variants in their NOD2 gene render-
ing them more susceptible to M.tb infection (Austin et al.,
2008). In addition, polymorphisms in CARD15, which
encodes NOD2, have been linked to inflammatory dis-
eases, including Crohn’s disease (Hugot et al., 2001; Le
et al., 2007), whose cause is speculated to be of bacterial
origin (Sartor, 2006). The association of Crohn’s disease
with Mycobacterium avium subsp. paratuberculosis con-
tinues to be reported (Hermon-Taylor, 2009).
The majority of studies to examine the role of NOD2 in
the host response to M.tb infection have been performed in
mice, murine macrophages or in transfected cell lines
(Ferwerda et al., 2005; Gandotra et al., 2007; Yang et al.,
2007; Divangahi et al., 2008; Pandey et al., 2009). There
are limited reports using either normal peripheral blood
mononuclear cells (PBMCs), PBMCs from patients with the
NOD2 mutation associated with Crohn’s disease, mixed
bronchoalveolar lavage (BAL) leucocytes, and none
using human monocyte-derived macrophages (MDMs)
(Ferwerda et al., 2005; Lala et al., 2007). A recent report
indicates that NOD2 and TLR pathways are non-redundant
in the recognition of M.tb, but can synergize to induce a
robust pro-inflammatory response (Ferwerda et al., 2005).
In addition, it has been shown in bone marrow-derived
murine macrophages (BMMs) that RIP2 polyubiquitination
occurs during M.tb incubation in a NOD2-dependent
manner (Yang et al., 2007). Other studies in mouse mac-
rophages have shown that NOD2 does not have a signifi-
cant role in controlling M.tb growth during early infection
(Gandotra et al., 2007) but may have during late infection
(Divangahi et al., 2008). A decrease in pro-inflammatory
cytokine production was observed in mouse NOD2 knock-
out BMMs and naive murine AMs in response to M.tb
without affecting intracellular bacterial growth (Gandotra
et al., 2007; Divangahi et al., 2008).
Interest in the potential interactions between M.tb and
cytosolic PRRs such as NOD2 continues to grow based
on recent reports that M.tb secretes virulence factors and
immune activators or suppressors through a type VII
secretion system (Abdallah et al., 2007; Ganguly et al.,
2008; Simeone et al., 2009). Other reports provide evi-
dence that M.tb may be able to escape the phagosome to
the cytosol under specific conditions (McDonough et al.,
1993; van der Wel et al., 2007).
Based on the known differences between human and
mouse macrophages in receptor expression, signalling
pathways and innate immune function (Schneemann and
Schoedon, 2002; Mestas and Hughes, 2004; Powlesland
et al., 2006; Schneemann and Schoeden, 2007), we
decided to study NOD2 in human macrophages and in
response to M.tb by optimizing an antibody to NOD2 and
by accomplishing effective small interfering RNA (siRNA)-
mediated knock-down of NOD2 in these cells. We show
that NOD2 expression increases during monocyte differ-
entiation. In contrast to previously published work using
mouse macrophages, we report that NOD2 is important in
controlling both pro-inflammatory cytokine production and
the growth of M.tb in human macrophages; whereas
NOD2 controls the growth of the related attenuated Myco-
bacterium bovis BCG (BCG) strain in both human and
mouse macrophages.
Results
NOD2 mRNA and protein expression increase as
monocytes differentiate into macrophages
The expression of NOD2 in human macrophages has not
been studied and there are few reports on NOD2 mRNA
expression in human monocytes (Ogura et al., 2001a; Lala
et al., 2007). We began our studies by determining the
expression of NOD2 during monocyte differentiation to
MDMs in an established model by quantitative real-time
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PCR (qRT-PCR) and Western blot (Henning et al., 2008).
Results from qRT-PCR provide evidence that NOD2 tran-
script levels are increased during the differentiation of
monocytes to macrophages. While we saw production of
mRNA in day 1 monocytes, the results in Fig. 1A show a
significant increase in mRNA at day 3 of differentiation
which remains elevated as the cells differentiate further
into mature macrophages. Next, we compared the mRNA
levels with the amount of protein produced during cell
differentiation by Western blotting. Due to the sensitivity
and specificity issues in using antibodies specific for
human NOD2, we optimized an available commercial anti-
body (ProSci) with human macrophage lysates. The speci-
ficity of this antibody was confirmed by a peptide
Fig. 1. NOD2 expression increases during monocyte differentiation to macrophages. PBMCs were harvested from Teflon wells each day from
day 1 through day 5 and monocytes/MDMs plated on tissue culture plates, and incubated at 37°C/5% CO2 for 2 h. The resultant
monocyte/MDM monolayers were either lysed with TRIzol for extraction of total RNA or TN-1 lysis buffer for cell lysate preparation.
A. NOD2 steady-state mRNA levels were measured during monocyte to macrophage differentiation by real-time PCR. Data were normalized
to the b actin gene and RCN was determined. Shown are cumulative data obtained from three independent experiments each performed in
triplicate (mean  SEM, *P < 0.05).
B. NOD2 antibody specificity was confirmed by peptide blocking using twofold excess NOD2 peptide (used to generate the NOD2 antibody)
and Western blotting using anti-NOD2 antibody. Shown is a representative blot from two independent experiments.
C. HEK293T vector (lane 1) and HEK293T cells expressing NOD2 (lane 2) were lysed and 100 mg of total protein in each case was
immunoprecipitated with NOD2 antibody (Cayman Chemicals) or isotype control (IgG1 kappa) and subsequent Western blots of the
immunoprecipitants probed with NOD2 antibody (ProSci). Shown is a representative Western blot from two independent experiments.
D. Monocyte/macrophage cell lysates were analysed for NOD2 protein expression by Western blot using NOD2 antibody. The same
membrane was re-probed with b actin to verify equal loading of lysate proteins. Shown is a representative Western blot and the bar graph
shows the cumulative densitometric analysis of Western blots from three different donors (mean  SEM, *P < 0.05, **P < 0.005).
E. Day 5 MDM monolayers on coverslips were fixed, permeabilized and stained using either NOD2 antibody or isotype control antibody
followed by Alexa Flour 488-conjugated secondary antibody. Cells were then examined by confocal microscopy (Olympus FV1000). Shown is
a representative section (63¥ magnification) of a Z series image from one of three independent experiments performed on duplicate
coverslips.
404 M. N. Brooks et al.
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 13, 402–418
competition assay (Fig. 1B), an immunoprecipitation (IP)
experiment (Fig. 1C) and in siRNA experiments shown
later. For IP experiments, proteins in cell lysates from
HEK293T cells expressing human NOD2 or HEK293T
cells containing the empty vector were immunoprecipitated
with NOD2 antibody (Cayman Chemical) and then probed
with NOD2 antibody from ProSci. As shown in Fig. 1C,
NOD2 antibody specifically binds to the human NOD2
protein expressed in the HEK293T cell line. We were also
able to detect NOD2 in human lysates using the antibody
available from eBioscience, although with more back-
ground (data not shown). Thus, in all subsequent experi-
ments we used the antibody from ProSci. In accordance
with the mRNA studies, NOD2 protein levels in cell lysates
increased markedly at day 3 of differentiation and
remained high on day 5 MDMs (Fig. 1D, upper panel). The
densitometric analysis of Western blots from three inde-
pendent experiments shows that NOD2 protein expression
levels increased during cell differentiation (Fig. 1D, lower
panel). Finally, our results were confirmed using confocal
microscopy where NOD2 protein was easily detected
throughout MDMs in a punctuate appearance (Fig. 1E).
Activation of NOD2 enhances the M.tb- and
BCG-mediated pro-inflammatory cytokine response
through the NF-kB pathway
We next investigated whether activation of NOD2 leads
to an increase in the M.tb- and BCG-mediated pro-
inflammatory cytokine response in macrophages. Incuba-
tion of macrophages with MDP, a NOD2 agonist, is known
to induce the production of pro-inflammatory cytokines
such as IL-1b (Li et al., 2004). A recent report indicates that
in some TB patients, NOD2 mRNA is enhanced in PBMCs;
furthermore, patients on anti-tuberculosis treatment have
enhanced NOD2 levels in leucocytes (Lala et al., 2007).
MDMs were pre-incubated with the NOD2 ligand MDP for
90 min followed by incubation with M.tb or BCG as
described in Experimental procedures in the presence of
MDP. Cell-free culture supernatants were analysed for
TNF-a and IL-1b secretion at 24 h. The data show an
additive (TNF-a) or synergistic (IL-1b) effect on cytokine
production in cells pre-treated with MDP compared with
cells incubated with mycobacteria alone (Fig. 2A and B).
Thus, our results indicate that pre-engagement of NOD2
by its ligand significantly enhances M.tb- or BCG-mediated
pro-inflammatory cytokine production. This effect is likely
due to the activation of NF-kB through the phosphorylation
of IkBa and its subsequent degradation (Karin and Ben-
Neriah, 2000; Yang et al., 2007).
To further explore the signalling pathway(s) involved,
we examined whether M.tb- or BCG-mediated signalling
events include those known for the NOD2 pathway. NOD2
engagement leads to recruitment of a serine threonine
kinase adapter protein called RIP2 by an electrostatic
interaction through their CARD domains, which in turn
causes autophosphorylation of RIP2 at serine 176 (Nem-
brini et al., 2009) in cell lines and murine macrophages.
Activated RIP2 phosphorylates inhibitor of kBa (IkBa)
resulting in the activation and translocation of NF-kB.
MDMs were incubated with M.tb or BCG for different time
points and the cell lysates were analysed for activation of
RIP2 and IkBa by Western blotting of the phosphorylated
proteins. The data show that both M.tb and BCG phos-
phorylate RIP2 during incubation but with different kinet-
ics and pattern. BCG- and M.tb-mediated phosphorylation
of RIP2 peaks at 30 min and 1 h, respectively, and the
phosphorylation decreased at 3 h during M.tb incubation
(Fig. 2C). M.tb and BCG infection also leads to phospho-
rylation of serine 32 of IkBa (Fig. 2D) which is known to
result in its degradation and subsequent activation of
NF-kB. We found that phosphorylation occurs as early as
15 min for both mycobacteria and continues through 2 h
for BCG but not M.tb. In addition, there is a decrease at
30 min which can be explained by the degradation of IkBa
and recruitment of newly re-synthesized pools of IkBa
from the cytoplasm, as previously described (Karin and
Ben-Neriah, 2000).
siRNA-mediated knock-down of NOD2 activity in human
macrophages leads to loss of its activity
In order to more definitively examine the causal role of
NOD2 in controlling the nature of the inflammatory
response and growth of mycobacteria in human mac-
rophages, we developed an effective and reliable proto-
col for knock-down of NOD2 in human macrophages by
using NOD2-specific siRNA and Amaxa nucleofector
reagent. MDMs were transfected with scramble siRNA or
NOD2-specific siRNA under optimized conditions, plated
in tissue culture plates, and lysed after 72 h and 96 h.
The cell lysates were analysed for NOD2 protein levels
by Western blotting. Results shown in Fig. 3A demon-
strate the loss of NOD2 protein in MDMs transfected
with NOD2-specific siRNA at both time points. These
results were confirmed by confocal microscopy (Fig. 3B).
Cell enumeration of scramble siRNA- and NOD2
siRNA-treated MDMs evaluated at 72 h post nucleofec-
tion by napthol blue black nuclear staining of cells dem-
onstrated no loss of cells on the monolayer in either
experimental group (Fig. 3C). There was also no differ-
ence in monolayer cell viability as seen by trypan blue
exclusion staining (95% viable in both groups, data not
shown). An assay was performed in order to verify that
NOD2 protein knock-down led to loss of its function.
Scramble siRNA- and NOD2 siRNA-transfected mac-
rophages were treated with MDP and the cell-free
culture supernatants were analysed for TNF-a produc-
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tion (Fig. 3D). NOD2 knock-down led to a significant
reduction in TNF-a production in response to MDP. We
also tested the specificity of NOD2 knock-down by
stimulating the NOD2 siRNA-transfected MDMs with the
NOD1 ligand H-Ala-D-g-Glu-diaminopimelic acid (iE-
DAP) and measured TNF-a levels in the supernatant.
There was no significant change in NOD1-mediated
TNF-a production between scramble siRNA- and NOD2
siRNA-transfected cells providing evidence that NOD2
knock-down by siRNA did not affect the activity of
NOD1, another NLR family member (Fig. 3D). We also
found that expression of the effector proteins TLR2, Syk
and total RIP2 is unaffected in scramble siRNA- and
NOD2 siRNA-transfected MDMs during M.tb and BCG
infection (Fig. 3E).
NOD2 regulates the macrophage TNF-a and IL-1b
cytokine response to M.tb and BCG
We next investigated whether NOD2 regulates the pro-
duction of pro-inflammatory cytokines during myco-
bacterial infection which can control the host defence
response through autocrine and paracrine functions
(Flesch and Kaufmann, 1993). Results shown in Fig. 2
had already indicated a potential link between NOD2
and the cytokine response to mycobacteria. Scramble
and NOD2 siRNA-transfected MDM monolayers were
incubated for 72 h to achieve the maximum NOD2
knock-down and subsequently incubated with M.tb or
BCG (moi 5:1) for 24 h. The cell-free culture superna-
tants were analysed for cytokine levels by ELISA. We
found that NOD2 deficiency leads to a significant
decrease in the production of TNF-a and IL-1b in
response to M.tb and BCG (Fig. 4A and B). Next, we
examined RIP2 activation in NOD2 knock-down MDMs
in response to M.tb and BCG infection. NOD2-deficient
MDM monolayers were incubated with M.tb or BCG for
short time periods and cell lysates were analysed for
RIP2 phosphorylation by Western blot. Our results show
that NOD2 siRNA-transfected MDMs have a partial but
reproducible decrease in RIP2 phosphorylation (Fig. 4C:
upper panel, Western blot; lower panel, band densitom-
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Fig. 2. The NOD2 ligand MDP enhances M.tb- and BCG-mediated cytokine production in human macrophages, a process involving activation
of RIP2 and IkBa.
A and B. MDM monolayers in a 24-well tissue culture plates were pre-incubated with or without MDP (5 mg ml-1) for 90 min and then incubated
with M.tb or BCG (moi 5:1) for 2 h, washed three times and repleted with MDP (5 mg ml-1) in RPMI with 1% autologous serum for 24 h.
Supernatants were collected and the amounts of TNF-a (A) and IL-1b (B) were measured by ELISA. Shown is the mean  SD of a
representative experiment performed in triplicate (n = 5, *P < 0.05).
C and D. In parallel, MDMs were incubated with M.tb or BCG (moi 5:1) for different time points and cells were lysed with TN-1 lysis buffer for
RIP2 (C) and IkBa (D) phosphorylation, and re-probed with b actin as a loading control. Shown is a representative Western blot from three
independent experiments.
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etry), particularly at 2 h, compared with scramble siRNA-
transfected MDMs in the case of both M.tb and BCG.
The partial reduction of RIP2 phosphorylation may be
explained by the fact that the mycobacteria also produce
NOD1 agonists that activate RIP2 independently of
NOD2. The smaller reduction of RIP2 phosphorylation in
NOD2 knock-down cells incubated with M.tb compared
with BCG may relate to the amount of the NOD1 agonist
DAP in the former (Phiet et al., 1976).
Expression of NOD2 in human AMs and its role in
regulating the production of TNF-a and IL-1b in
response to M.tb
A recent report showed the presence of NOD2 tran-
scripts in human alveolar lavage cells, but to date
there is no evidence for the presence of NOD2 protein
in AMs (Lala et al., 2007). Therefore we examined
whether NOD2 protein is expressed in human AMs. Cell
Fig. 3. Loss of NOD2 activity in human macrophages by siRNA knock-down. MDMs were transfected with either 368 nM scramble siRNA or
NOD2 siRNA using the Amaxa nucleofector.
A. The transfected macrophages were plated in RPMI containing 20% autologous serum and incubated for the indicated time points
(72 h and 96 h). At each time point macrophages were lysed and NOD2 or the loading control b actin protein levels were examined by
Western blot (representative blot from n = 3).
B. NOD2 or scramble siRNA-transfected MDM monolayers on coverslips were incubated for 72 h, washed, fixed, permeabilized and stained
using either NOD2 antibody or isotype control antibody followed by Alexa Flour 488-conjugated secondary antibody. Cells were then examined
by confocal microscopy. Shown is a representative micrograph from the Z series (63¥ magnification for isotype; 126¥ magnification for
scramble/NOD2 siRNA, n = 3).
C. Cell numbers were assessed 72 h post transfection to ensure equal numbers of cells between scramble siRNA- and NOD2
siRNA-transfected cells. Nuclei in cell lysates were counted on a haemacytometer after nuclei were stained with Napthol blue black. Shown
are cumulative data obtained from three independent experiments each performed in triplicate (mean  SEM).
D. Scramble siRNA- or NOD2 siRNA-transfected MDM monolayers in culture for 72 h were treated with MDP (5 mg ml-1) or DAP (10 mg ml-1)
for 24 h. Cell supernatants were analysed for TNF-a by ELISA. Shown is a representative experiment performed in triplicate (mean  SD,
n = 2, **P < 0.005; NS P = 0.1519).
E. Scramble siRNA- or NOD2 siRNA-transfected MDM monolayers were incubated with M.tb or BCG (moi 5:1) for the indicated time points
(15 min and 2 h) and cells were lysed with TN-1 buffer. TLR2, Syk and RIP2 were analysed by Western blot. Shown is a representative
experiment of two independent experiments.
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lysates were prepared from MDMs and AMs, the
latter were isolated from healthy donors and both
cell types were analysed for NOD2 expression by
Western blot. Results shown in Fig. 5A demonstrate
that AMs express a detectable amount of NOD2 pro-
tein but the level is less than that in an equivalent
number of MDMs. To further examine the potential
involvement of NOD2 in the production of inflammatory
cytokines in response to M.tb, we incubated AMs with
or without MDP and then with M.tb (moi 1:1) for 24 h.
The cell culture supernatants were analysed for TNF-a
and IL-1b production. We found that MDP or M.tb
treatment induces the production of TNF-a whereas
only M.tb induces the production of IL-1b, and that
the levels of both cytokines were further enhanced
by the addition of both MDP and M.tb (Fig. 5B and C).
The magnitude of the responses was relatively low
when compared with the response seen with MDMs
(Fig. 2). Together, these results provide evidence that
AMs express functional NOD2 protein in the lung
microenvironment, albeit with lower activity than in
MDMs.
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Fig. 4. NOD2 controls M.tb- and BCG-mediated cytokine production and RIP2 activation in human macrophages.
A and B. Scramble or NOD2 siRNA-transfected MDM monolayers were incubated with M.tb or BCG (moi 5:1) for 2 h, washed three times with
warm RPMI and repleted in 1% autologous serum for 24 h. Cell culture supernatants were analysed for TNF-a (A) and IL-1b (B) production by
ELISA. The graphs shown are from a representative experiment of n = 3. *P < 0.05 or **P < 0.005.
C. Scramble- or NOD2 siRNA-transfected MDM monolayers were incubated with M.tb or BCG (moi 5:1) for the indicated time points (15 min
and 2 h) and cells were lysed with TN-1 buffer. NOD2-dependent RIP2 phosphorylation was analysed by Western blot of cell lysates from
scramble- and NOD2-deficient MDMs (upper panel). Shown is a representative experiment of three independent experiments. Densitometry of
the band intensities in this experiment is shown as a bar graph (lower panel).
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NOD2 controls the intracellular growth of M.tb and BCG
in human macrophages
We next focused our studies on determining the role of
NOD2 in controlling the growth of mycobacteria in
human macrophages. MDMs were transfected with
scramble or NOD2 siRNA and after 72 h of transfection,
macrophages were incubated with M.tb or BCG (moi 5:1)
for 24 h. Experiments were performed for 24 h due to the
fact that NOD2 protein levels in macrophages began to
reappear after 120 h of knock-down. Intracellular growth
of M.tb and BCG was determined by a colony-forming
unit (cfu) assay (Olakanmi et al., 2000). The results in
Fig. 6A show that silencing of NOD2 in macrophages
significantly enhances the growth of M.tb (84.6  8.0%,
n = 3). A similar result was observed for BCG growth in
Fig. 6B (108.4  30.4%, n = 5). Western blotting con-
firmed NOD2 knock-down in each experiment (Fig. 6C).
We next determined whether the increase in mycobac-
terial growth at 24 h was the result of increased cell
association (both bacterial attachment and phagocyto-
sis). We compared the association of bacteria with
scramble and NOD2 siRNA-transfected MDMs by phase-
contrast and fluorescence microscopy after 2 h infection.
Our results show that bacterial association is not altered
by NOD2 siRNA transfection (Fig. 6D and E). Thus,
these results indicate that NOD2 plays a role in regulat-
ing the early host defence response during infection of
both M.tb and BCG.
Effects of NOD2 on M.tb and BCG growth in mouse
macrophages and on the cytokine response to infection
Previous studies have reported that NOD2 is not critical
for controlling the growth of M.tb and BCG in mouse
macrophages (Gandotra et al., 2007; Divangahi et al.,
2008). Based on our results in human macrophages, we
elected to examine the host response to these myco-
bacteria in mouse macrophage experiments. We repro-
duced the published finding that NOD2 does not control
the growth of M.tb in mouse macrophages using wild-
type (WT) and NOD2-/- BMMs (Fig. 7A). In contrast to
the published work with BCG that analysed growth in
naive murine AMs at 48 h (Divangahi et al., 2008), our
data show that NOD2 is important in controlling the
growth of BCG at the later time points of 72 h and 168 h
in WT and NOD2-/- BMMs (Fig. 7B). We also examined
the cell association of bacteria with WT and NOD2-/-
BMMs by microscopy and found no difference with M.tb
and only a small difference with BCG (Fig. 7C and D).
Finally, consistent with the literature, we found a reduc-
tion in the pro-inflammatory cytokine IL-1b in response
to M.tb and BCG at 24 h, 72 h and 168 h in NOD2-/-
BMMs (Fig. 7E).
Discussion
Macrophages play a critical role in the recognition and
removal of pathogens through various PRRs, including
intracellular receptors such as NLR family CARD-
containing domain 4 (NLRC4), baculoviral IAP repeat-
containing protein 1 (NAIP), NOD1 and NOD2. Studies on
host recognition of pathogens by human macrophages
have demonstrated the importance of transmembrane
receptors; however, the field is relatively lacking in defin-
ing the role of intracellular receptors in these cells. NOD2
is an intracellular PRR that senses bacteria through its
LRR domain and induces a pro-inflammatory response.
While this inflammatory response can activate the mac-
rophage, it also allows for the recruitment and activation
of other immune cells to the site of infection. NOD2 has
R MDP M.tb MDP → M.tb
0
250
500
750
IL
-1
β (
pg
 m
l−
1 )
*
C.
R MDP M.tb MDP → M.tb
0
500
1000
1500
2000
2500
T
N
F-
α
 (
pg
 m
l−
1 )
B.
*
A.
IB: β Actin
IB: NOD2
A
M
D
ay
 5
 M
D
M
Fig. 5. M.tb-mediated cytokine production in human AMs treated with MDP.
A. The NOD2 expression level in healthy donor AMs was compared with day 5 MDMs using protein-matched cell lysates by Western blot with
a NOD2-specific antibody and b actin as a loading control. Shown is a representative blot of two independent experiments.
B and C. AMs were pre-incubated with MDP (5 mg ml-1) or media alone for 90 min and then incubated with M.tb (moi 1:1) for 2 h, washed
three times and repleted with MDP in 1% autologous serum for 24 h. Culture supernatants were measured for TNF-a (B) and IL-1b (C)
production by ELISA. Shown is a representative experiment of the mean  SD of triplicate wells in each test group (n = 2, *P < 0.05).
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been shown to serve as a microbial sensor and activator
of the pro-inflammatory response to several pathogens,
including M.tb (Opitz et al., 2004; Ferwerda et al., 2005;
Kobayashi et al., 2005; Gandotra et al., 2007; Herskovits
et al., 2007; Kapetanovic et al., 2007; Divangahi et al.,
2008). In the case of Helicobacter pylori, it is thought that
the bacterium is able to use a secretion system to secrete
peptidoglycan fragments that are then recognized by
NOD2 in the cytosol (Franchi et al., 2008). Since M.tb is
an intracellular pathogen, and known to secrete virulence
factors, it is necessary to understand the role of intracel-
lular receptors and immune functions in human macroph-
ages with regards to this pathogen. Demonstrating a role
for NOD2 can lead to the development of new methods for
targeting this host defence molecule/pathway for therapy
in the case of M.tb.
The presence of NOD2 mRNA has only been reported
in monocytes (Ogura et al., 2001a). Thus, we initiated
studies of NOD2 mRNA transcript levels as monocytes
differentiate into macrophages using an established in
vitro model. Our results indicate that NOD2 steady-state
mRNA transcripts increase as monocytes differentiate
into macrophages, specifically on day 3 of differentiation.
This result is similar to our previously published data on a
membrane PRR that recognizes M.tb, the MR, whose
mRNA transcript levels are also enhanced in macroph-
ages when compared with monocytes. On the other hand,
TLR2 and TLR4 expression follows a different pattern on
these cells (Henning et al., 2008).
Since mRNA levels do not always correlate with protein
expression, we elected to explore NOD2 protein expres-
sion in human macrophages compared with monocytes.
Studies in the field have been limited to assaying for
mRNA levels in primary human cells; whereas protein
expression has been studied in cell lines by flag tagging
NOD2 (Barnich et al., 2005; Legrand-Poels et al., 2007).
Thus, a major contribution to the field by the current
work is the optimization of available antibodies for
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Fig. 6. NOD2 controls the intracellular growth of M.tb and BCG in human macrophages.
A and B. Scramble or NOD2 siRNA-transfected MDMs in monolayer culture for 72 h were incubated with M.tb or BCG (moi 5:1) for 2 h,
washed three times with warm RPMI, repleted in 1% autologous serum for 24 h and lysed to analyse cfu for (A) M.tb growth and (B) BCG
growth. Shown is a representative experiment (mean  SD of triplicate wells in each test group) for each bacterium (for M.tb n = 3 and for
BCG n = 5; *P < 0.05).
C. Western blot in the experiment shown confirming NOD2 knock-down.
D and E. Mycobacterial association with macrophages was assessed by phase-contrast and fluorescent microscopy. Scramble or NOD2
siRNA-transfected MDMs were plated on coverslips for 72 h and then incubated with M.tb (D) or BCG (E) for 2 h (moi 10:1). Cells were then
washed, fixed in 10% formalin, mycobacteria were stained with auramine-rhodamine and enumerated as bacteria per macrophage. Cumulative
data from three independent experiments, each performed in triplicate, are shown as fold change relative to the scramble siRNA condition
(mean  SEM).
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Fig. 7. Effect of NOD2 on M.tb and BCG growth and cytokine response in mouse WT and NOD2-/- BMMs.
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C and D. Cell association of M.tb (C) and BCG (D) with WT and NOD2-/- BMMs was analysed at 2 h post infection by microscopy. Cumulative
data from three independent experiments, each performed in triplicate, are shown as fold change relative to WT condition (mean  SEM,
*P < 0.05).
E. The cytokine response IL-1b was analysed by ELISA in culture supernatants harvested from M.tb- and BCG-infected WT and NOD2-/-
BMMs. The data shown are from a representative experiment (mean  SD, n = 2, with four test results in each group, *P < 0.05; **P < 0.005,
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characterization of NOD2 protein expression in primary
human monocytes/macrophages by Western blot and
confocal microscopy. Our findings demonstrate that
NOD2 protein is expressed in human macrophages and
levels increase during monocyte to macrophage differen-
tiation, suggesting a particularly important role for NOD2
in human macrophages. Our microscopy results show
NOD2 protein in a punctuate pattern in cells, suggesting
the possibility that it resides within organelles or in com-
plexes present in the cytoplasm.
We also detected NOD2 protein in human AMs from
healthy donors. An interesting finding in our work is that
AMs appear to express less of NOD2 protein than MDMs.
It is possible that reduced NOD2 levels in AMs represent
another phenotypic marker of alternatively activated mac-
rophages of which AMs are a prototype and consequently
lead to less effective killing of M.tb on first contact during
the innate immune response. On the other hand, later
during TB disease, NOD2 may play an important role in
host defence since NOD2 mRNA levels are increased in
patients with TB disease (Lala et al., 2007).
NOD2 is engaged in response to pathogens which
leads to the production of pro-inflammatory cytokines. In
cell lines expressing NOD2, incubation with M.tb
enhances NF-kB activation (Ferwerda et al., 2005; Cou-
lombe et al., 2009). We found that pre-stimulation of
human macrophages (both MDMs and AMs) with the
NOD2 ligand MDP followed by M.tb or BCG incubation
caused a significant increase in TNF-a and IL-1b pro-
duction. Although the addition of MDP is not the para-
digm for human infection, the result provided evidence
for the potential involvement of NOD2 in augmenting the
cytokine response to M.tb and BCG. This result raised
the question as to what are the major downstream sig-
nalling kinases activated in response to M.tb or BCG.
RIP2 is a kinase that autophosphorylates at serine 176,
and its kinase activity is necessary for NOD2-mediated
pro-inflammatory cytokine production (Nembrini et al.,
2009). We found that M.tb and BCG both activate RIP2
by phosphorylation at serine 176 in a NOD2-dependent
manner; however, the kinetics and pattern of activation
were different for these two bacteria. RIP2 phosphoryla-
tion peaked earlier for BCG (30 min) and continued
throughout the time-course; whereas RIP2 phosphoryla-
tion peaked at 1 h for M.tb and the level of phosphory-
lation decreased by 3 h. Consistent with this we
observed that BCG continues to activate downstream
IkBa [thereby enabling the transcriptional activity of
NF-kB and the resultant upregulation of expression of
macrophage pro-inflammatory response genes (Karin
and Ben-Neriah, 2000)] through 2 h whereas activation
of IkBa decreases for M.tb at this time point. Thus, it
appears that M.tb but not BCG can downregulate RIP2
and IkBa activation perhaps as a mechanism to dampen
the innate immune response. One possibility for this
downregulation is that M.tb possesses virulence factors
that affect this pathway that are not present in BCG
such as those present in the Region of Difference-1
(RD1) which is responsible for the production of several
virulence-associated proteins in M.tb (Abdallah et al.,
2007). For example, culture filtrate protein-10 kDa (CFP-
10) and early secreted antigenic target-6 kDa (ESAT-6)
in M.tb but not in BCG have been shown to inhibit
lipopolysaccharide-induced NF-kB transactivation by
inhibiting reactive oxygen species production (Ganguly
et al., 2008). Apart from RIP2, recent work from our
laboratory has identified a PPARg-mediated pathway for
M.tb that is not operative for BCG in human macroph-
ages (Rajaram et al., 2010).
To more directly assess a causal role for NOD2 in
regulating the inflammatory response to mycobacteria in
primary human macrophages, we developed a reliable
knock-down protocol for NOD2 that is specific and does
not appreciably affect the viability of the cells on the
monolayer. To date, studies on the role of NOD2 in
response to different pathogens in primary human cells
have relied on either expressing the NOD2 allele with the
Crohn’s disease mutation in cell lines (Ogura et al.,
2001b) or by obtaining cells from individuals homozygous
for the NOD2 mutation, which was shown to render this
protein reduced in activity or non-functional (Inohara
et al., 2003). Obtaining cells from Crohn’s disease
patients with this mutation is difficult and the results may
not be consistent among patients. Also, since these
patients have a mutation in this protein, their cells may be
primed in other ways that may alter the immunological
response. The accomplished knock-down of NOD2 in
human macrophages is an important advance enabling
the study of NOD2 more comprehensively in primary
monocytes/macrophages.
Our results are consistent with those found with mouse
macrophages with regards to the role of NOD2 in control-
ling the inflammatory response to mycobacteria. Gan-
dotra et al. found that TNF-a and IL-12 production is
decreased in NOD2 knockout BMMs in response to M.tb
(Gandotra et al., 2007) and Divangahi et al. found that
these cytokines are decreased in NOD2 knockout naive
alveolar mouse macrophages in response to BCG (Divan-
gahi et al., 2008). We observed that both TNF-a and IL-1b
production are significantly reduced in NOD2-deficient
human macrophages and found a decrease in RIP2 phos-
phorylation in response to M.tb and BCG infection. It is
noteworthy that RIP2 activity is only partially reduced
rather than abolished by the knock-down of NOD2, which
may be due to the activation of RIP2 by other intracellular
receptors. For example, NOD1 is involved in the
activation of RIP2 through the CARD–CARD interaction
(Nembrini et al., 2009).
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The role of NOD2 in IL-1b production during M.tb and
BCG infection is of interest. A recent publication reports
that PBMCs from Crohn’s disease patients that are
homozygous for the 3020insC NOD2 mutation exhibit
decreased production of IL-1b in response to M.tb (Klein-
nijenhuis et al., 2009). The mechanism for the production
of mature IL-1b in response to M.tb involved the activation
of ERK, p38 and RIP2 following recognition by TLR2/
TLR6 and NOD2 in PBMCs; however, the mechanism
was not explored in human macrophages. In PBMCs,
NOD2 is reported to have a dual effect on pro-IL-1b
mRNA transcription and secretion of mature IL-1b (Fer-
werda et al., 2008). Our preliminary observations suggest
that during M.tb infection, NOD2 knock-down macroph-
ages demonstrate either no effect or an increase in pro-
IL-1b transcription. On the other hand NOD2 does appear
to play a role in caspase-1 activation during M.tb infection
(M. Brooks et al., unpubl. data). In our results in which we
added MDP to untransfected macrophages followed by
M.tb infection, we observed an additive effect on TNF-a
secretion, but a synergistic effect on IL-1b secretion
(Figs 2 and 5). We speculate that the differential response
of TNF-a and IL-1b may be explained by NOD2 being
relatively more important in the release of mature IL-1b
due to a role in processing pro-IL-1b through caspase-1.
The relationship between NOD2 and caspase-1 has been
reported (Pan et al., 2007; Hsu et al., 2008).
Previous studies have reported that NOD2 knockout in
mouse macrophages has no effect on controlling M.tb
growth (Gandotra et al., 2007; Divangahi et al., 2008). In
contrast, we demonstrate here for the first time that NOD2
plays a role in controlling intramacrophage growth of M.tb
and BCG in human macrophages. The difference in the
role of NOD2 in controlling mycobacterial growth is vali-
dated by doing a direct side by side comparison of myco-
bacterial growth in NOD2-deficient human macrophages
and macrophages from NOD2 knockout mice. This differ-
ence can be generally explained by the growing list of
differences seen in the innate immune response of human
versus mouse macrophages (Bogdan, 2001; Mestas and
Hughes, 2004; Boot et al., 2005; Reginato and Olsen,
2007; Rigamonti et al., 2008; Gavrilin et al., 2009; Amer,
2010). It is relevant that the NOD2 knockout mouse does
not show any signs of abnormalities in the intestinal tract,
which is inconsistent with the NOD2 mutations leading to
Crohn’s disease and inflammatory bowel disease in
humans (Pauleau and Murray, 2003). In addition, differ-
ences in promoter structure between humans and mice
indicate divergent mechanisms in NOD2 regulation (Hu
et al., 2010).
There have been reports over time providing evidence
that M.tb can translocate into the cytosol of macrophages
under defined conditions (Leake et al., 1984; Myrvik et al.,
1984; McDonough et al., 1993; van der Wel et al., 2007)
and also that mycobacterial phagosomes are porous
(Teitelbaum et al., 1999). Nonetheless, the weight of the
evidence to date is that mycobacteria replicate in phago-
somes in human and mouse macrophages. In the context
of the current work, we speculate that M.tb interacts with
NOD2 by either secreting virulence factors from the pha-
gosome into the cytosol via a secretion system(s) (Abdal-
lah et al., 2007; Pandey et al., 2009), or possibly
translocates proteins across the phagosome through the
action of a yet to be defined flippase. Alternatively, a
NOD2–RIP2 complex has been reported to signal from
the cell membrane along with the need for NOD2 to be
present at the membrane of intestinal epithelial cells for
signalling to occur (Barnich et al., 2005; Lecine et al.,
2007). These reports raise the possibility that NOD2 may
localize with the phagosome of M.tb leading to engage-
ment of this cytosolic PRR during residence of the bacte-
rium within the phagosome.
The mechanism(s) involved in the recognition of NOD2
by M.tb and BCG may differ since BCG lacks the ESX-1
secretion system and is reported to be unable to stimulate
NOD2-dependent RIP2 polyubiquitination in murine mac-
rophages (Pandey et al., 2009). Nonetheless, BCG does
generate TNF-a in a NOD2-dependent manner (this
report and Coulombe et al., 2009). Of relevance, myco-
bacteria contain the N-acetyl muramic acid hydroxylase,
NamH, which glycosylates MDP causing it to be a more
potent stimulator of the immune response via NOD2 sug-
gesting that NOD2 may be more tuned at sensing myco-
bacterial infections in generating an immune response
(Coulombe et al., 2009).
In summary, here we report that NOD2 is present and
functional in human macrophages, including AMs. We
provide evidence that NOD2 plays a role in controlling the
growth of M.tb and BCG in human macrophages along
with regulating the nature of the inflammatory response.
The role for NOD2 differs with respect to growth of M.tb
and BCG in human and mouse macrophages. Finally, the
assays established and described in this report now
enable a more thorough evaluation of the role of NOD2 in
regulating the innate immune response of human mac-
rophages to mycobacteria and other infectious agents.
Experimental procedures
Buffers and reagents
Dulbecco’s PBS with and without Ca2+ and Mg2+ ions, Iscoves,
FBS, TRIzol and RPMI 1640 medium with L-glutamine were
purchased from Invitrogen (Invitrogen Life Technologies). RHH
medium [RPMI 1640 plus 10 mM HEPES (Invitrogen) plus 0.4%
human serum albumin (CSL Behring LLC)] was used for cell
culture experiments. N-Acetylmuramyl-L-alanyl-D-isoglutamine
hydrate (MDP; Sigma-Aldrich) and H-Ala-D-g-Glu-diaminopimelic
acid (iE-DAP; AnaSpec) were used for functional assays involv-
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ing ELISAs. 7H11 agar was prepared with Bacto Middlelebrook
7H11 agar, oleic acid-albumin-dextrose-catalase enrichment
medium and glycerol (Difco Laboratories).
Antibodies
Unconjugated rabbit anti-human NOD2 was purchased from
ProSci and another anti-human NOD2 antibody was obtained
from Dr Núñez’s laboratory and available by eBioscience. Syk
(N-19), TLR2, b actin, goat anti-rabbit IgG-HRP and donkey
anti-goat IgG-HRP antibodies were purchased from Santa Cruz
Biotechnology. The aforementioned antibodies were used for
Western blot. The NOD2 antibody from ProSci, Alexa Fluor 488-
conjugated goat anti-rabbit IgG (Molecular Probes and Invitro-
gen) and normal rabbit IgG (Santa Cruz Biotechnology) were
used for confocal microscopy experiments. Monoclonal anti-
human NOD2 (Cayman Chemical) and anti-mouse IgG1 kappa
(Abcam) were used for IP experiments. Antibodies specific for
phospho-RIP2 (Ser176) and phospho-IkBa (Ser32) were pur-
chased from Cell Signaling Technology.
Bacterial strains and culture
Lyophilized M.tb H37Rv (ATCC #25618) and BCG (ATCC #35734)
were obtained from American Tissue Culture Collection, recon-
stituted and used as described (Schlesinger et al., 1990). The
concentration of bacteria (1–2 ¥ 108 bacteria ml-1) and the
degree of clumping ( 10%) were determined by counting in a
Petroff–Hausser chamber. Bacteria prepared in this fashion are
 90% viable by cfu assay.
Isolation and culture of human monocytes and
macrophages
Blood obtained from healthy, Purified Protein Derivative negative
human volunteers using an approved protocol by The Ohio State
University Institutional Review Board (IRB) was processed as
described (Horwitz and Silverstein, 1980). Briefly, PBMCs were
isolated from heparinized blood on a Ficoll-Paque cushion
(Amersham Biosciences/GE Healthcare) and cultured in Teflon
wells (Savillex) for 1 (monocytes) through 5 (MDMs) days in the
presence of RPMI 1640 medium containing 20% autologous
serum (2.0 ¥ 106 PBMCs ml-1) at 37°C/5% CO2 (Beharka et al.,
2002). Human AMs were isolated from BALs of healthy human
donors as previously described (Gaynor et al., 1995) using an
approved protocol by The Ohio State University IRB. Briefly, the
BAL was centrifuged (200 g, 4°C, 10 min), supernatant was
removed, and the pellet resuspended in RPMI and washed two
more times with RPMI. AMs were plated in tissue culture plates
with 10% human serum supplemented with penicillin
(1000 U ml-1), incubated in CO2 incubator at 37°C for 2 h,
washed with warm RPMI to remove non-adherent cells and peni-
cillin, and used for experiments.
Mice and mouse macrophages
Wild-type C57BL/6 and NOD2-/- mice were backcrossed to
C57BL/6 background for 10 generations (Kobayashi et al., 2005).
BMMs were prepared from femurs of 5- to 8-week-old mice as
previously described (Brieland et al., 1994; Amer et al., 2006).
RNA isolation
One- to 5-day-old PBMCs in Teflon wells were harvested and
mononuclear phagocytes adhered to a six-well tissue culture
plate with 10% autologous serum (8 ¥ 106 PBMCs ml-1). After
washing away lymphocytes, the monocytes or MDMs (8 ¥ 105
cells) were lysed in TRIzol and total RNA was isolated by using
the Qiagen RNAeasy column method. The Experion (Bio-Rad)
was used to determine the quality and quantity of RNA samples.
Gene expression studies by qRT-PCR
RNA (100 ng) was reverse transcribed to cDNA by reverse tran-
scriptase enzyme (SuperScript II, Invitrogen) and qRT-PCR was
performed using a human NOD2 TaqMan gene expression kit
(Applied Biosystems). NOD2 amplification was normalized to b
actin as a housekeeping gene (DCt). Relative copy number
(RCN) and fold change were determined. RCN was calculated as
follows: RCN = E-DCt ¥ 100, where E is the efficiency (2 = 100%
efficiency) and Ct = Ct (target) - Ct (reference) (Gavrilin et al.,
2006). Fold change was calculated from RCN compared with day
1. Triplicate samples were analysed in duplicate wells in each
experiment.
Confocal microscopy
Untransfected MDMs or transfected (scramble siRNA or NOD2
siRNA) MDMs (2 ¥ 105) were adhered to a glass coverslip in a
24-well tissue culture plate for 2 h at 37°C and washed to remove
lymphocytes. The cells were washed, fixed with 2% paraformal-
dehyde (10 min at room temperature), permeabilized by treat-
ment with 100% methanol for 4 min, washed and then incubated
overnight in 10% non-fat milk in PBS as blocking reagent. The
cells were then incubated with NOD2 (2.5 mg ml-1) or the appro-
priate isotype (2.5 mg ml-1) control antibody for 1 h at room tem-
perature, washed with blocking reagent, and counterstained with
an Alexa Fluor 488-conjugated secondary antibody (1:500 dilu-
tion) for 1 h at room temperature. Nuclei were labelled with
0.1 mg ml-1 of the DNA stain 4,6-diamidino-2-phenylindole (DAPI;
Invitrogen/Molecular Probes) in PBS for 5 min at room tempera-
ture. The cells were next washed with PBS and coverslips were
mounted on glass slides. Slides were viewed using an Olympus
Flowview 1000 Laser Scanning Confocal microscope.
Transfection of MDMs
PBMCs were transfected with Accell scramble siRNA or NOD2
siRNA purchased from Thermo Scientific Dharmacon RNAi tech-
nologies that targeted the sequence CUUUAGGAUGUACAG-
UUA (368 nM) using the Amaxa Nucleofector (Lonza Group).
Briefly, PBMCs (1 ¥ 107) were resuspended in 100 ml of nucleo-
fector solution followed by the addition of 5 mg ml-1 scramble
siRNA or NOD2 siRNA, incubated at room temperature for 5 min
and nucleofected according to the manufacturer’s instructions.
PBMCs were then seeded on 12-well plates containing 1.0 ml of
RPMI supplemented with 10% autologous serum and incubated
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for 2 h at 37°C and 5% CO2. After 2 h, adhered transfected cells
(MDMs) were washed and repleted with warm RPMI containing
20% autologous serum for 72 h. Transfected cells were used for
subsequent experiments, such as cfu assays, cytokine assays,
confocal microscopy, cell enumeration assays and Western blot-
ting. Assessment of monolayer density in experiments was per-
formed as described below.
Macrophage stimulation/infection, cell lysis,
immunoprecipitation and Western blotting
Day 5 MDMs or MDMs transfected with scramble siRNA or NOD2
siRNA (2.0 ¥ 105) were incubated with M.tb or BCG (moi 5:1;
triplicate wells) in RHH for 30 min at 37°C in 5% CO2 on a
platform shaker for equal dispersion of bacteria followed by an
additional incubation for 90 min without shaking. The cells were
then washed three times with warm RPMI, repleted with RPMI
containing 1% human autologous serum and incubated for 24 h
at which time supernatants were collected for ELISAs (see
below). For experiments using the NOD2 ligand MDP, 2.0 ¥ 105
day 5 MDMs were adhered to a 24-well plate for 2 h at 37°C in
5% CO2, washed to remove lymphocytes and then incubated with
MDP (5 mg ml-1) for 90 min. Cells were then incubated with bac-
teria as described above (2 h total), washed and repleted with
MDP in 1% autologous serum for 24 h. Cell culture supernatants
were harvested and used for ELISAs. The monolayers were
washed once with PBS and lysed in TN-1 lysis buffer [50 mM Tris
(pH 8.0), 10 mM EDTA, 10 mM Na4PO7, 10 mM NaF, 1% Triton
X-100, 125 mM NaCl, 10 mM Na3VO4, 10 mg ml-1 aprotinin and
10 mg ml-1 leupeptin], incubated on ice for 10 min and then cen-
trifuged at 17 949 g for 10 min at 4°C to remove cell debris
(Rajaram et al., 2006). For infections, MDM monolayers were
incubated with M.tb or BCG in RHH for 15 min, 30 min, 1 h, 1.5 h,
2 h and 3 h (moi 5:1). At each time point, cells were washed with
PBS and lysed as above. For NOD2 knock-down assessment,
lysates were collected as above at 72 h and 96 h post knock-
down. Protein concentrations of the cleared lysates were mea-
sured using the BCA-protein assay kit (Pierce). Proteins were
separated by SDS-PAGE and analysed by Western blot by
probing with the primary and secondary antibody of interest and
development using ECL (Amersham Biosciences). For the IP
experiment whole-cell lysates were collected from HEK293T
(empty vector) and NOD2-expressing HEK293T cells. Equal
amounts of protein were incubated overnight with NOD2 antibody
(Cayman Chemicals) or control IgG1 kappa. Then cells were
incubated for 2 h with Protein G agarose beads (Invitrogen),
washed, pellets boiled in Laemmli buffer and loaded on a 7.5%
SDS-PAGE gel, and Western blot was performed using a
NOD2 antibody (ProSci). The protein band intensities were
measured using the online ImageJ software provided by the NIH.
Background intensity was subtracted from each sample and
then normalized to b-actin. Fold change was determined as
follows: (treated sample band intensity)/(untreated sample band
intensity).
ELISAs
For MDM experiments, cell-free culture supernatants were col-
lected at 24 h and used to measure TNF-a and IL-1b by ELISA
(R&D Systems). For mouse macrophage studies, WT and
NOD2-/- macrophage monolayers were incubated with serum-
opsonized mycobacteria (M.tb moi 1:1 and BCG moi 2.5:1) in the
same manner as described for MDMs. Cell-free culture superna-
tants were collected at 24 h, 72 h and 168 h and measured for
IL-1b by ELISA (BD Biosciences).
M.tb and BCG intracellular growth assays in
macrophages
A cfu assay using infected macrophage lysates was performed
as described (Olakanmi et al., 2000). Briefly, scramble siRNA- or
NOD2 siRNA-transfected MDM monolayers were incubated with
M.tb or BCG (moi 5:1; triplicate wells) in RHH for 30 min at 37°C
in 5% CO2 on a platform shaker for equal dispersion of bacteria
and for an additional 90 min stationary. The cells were then
washed three times with warm RPMI and either lysed or repleted
with RPMI containing 1% human autologous serum and incu-
bated for 2 h or 24 h. The supernatants and MDM monolayers
were then processed for ELISA or enumeration of cfu respec-
tively (triplicate samples in each test group). The number of
colonies was counted after 4 weeks and data analysed. For
mouse macrophage experiments, WT and NOD2-/- macroph-
ages were incubated with serum-opsonized mycobacteria (M.tb
moi 1:1 and BCG moi 2.5:1) in Iscoves plus 10% FBS using the
same incubation protocol as for MDMs and then lysed at 2 h,
24 h, 72 h and 168 h.
M.tb and BCG cell association assay with macrophages
Scramble siRNA- or NOD2 siRNA-transfected MDM monolayers
(2.0 ¥ 105), or WT or NOD2-/- mouse macrophages monolayers
(2.5 ¥ 105) were incubated with M.tb or BCG (moi 10:1; triplicate
wells) in RHH for 30 min at 37°C in 5% CO2 on a platform shaker
for equal dispersion of bacteria and then for an additional 90 min
without shaking. The cells were then washed three times with
warm RPMI and fixed with 10% formalin for 10 min at room
temperature.
Coverslips were then washed three times with PBS, dried and
cell-associated M.tb or BCG was stained with auramine-
rhodamine (BD Biosciences). Three hundred consecutive
macrophages/coverslip/test group were counted using phase-
contrast and fluorescence microscopy (Schlesinger, 1993).
Cell enumeration of NOD2 siRNA-transfected MDMs in
monolayer culture
Scramble siRNA- and NOD2 siRNA-transfected MDMs were
plated in 24-well plates and after 2 h, washed and repleted with
20% autologous serum for 72 h. Cells were then washed one
time with PBS and treated with 1% Cetavlon in 0.1 M citric acid
with 0.05% Napthol blue black (Sigma-Aldrich), pH 2.2, for
15 min at room temperature. Cell lysates were then loaded on a
haemacytometer and stained nuclei enumerated using phase-
contrast microscopy (Nakagawara and Nathan, 1983).
NOD2 antibody peptide competition assay
The NOD2 antibody and the NOD2 peptide (ProSci) used
to produce the antibody were incubated in a ratio of 2:1
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(peptide : antibody) at 37°C for 30 min in a 5% milk solution in
low-retention tubes. Day 5 MDM lysates were run in parallel on a
7.5% SDS-PAGE gel, transferred to a nitrocellulose membrane
and the membrane cut so that each lane could be probed with
either the antibody–peptide mixture or antibody alone overnight
at 4°C. Western blotting was performed as described above.
Membranes were then developed using ECL.
Statistics
A paired one-tailed Student’s t-test was used to analyse the
differences between two groups in figures showing one repre-
sentative figure of three independent experiments. An unpaired
one-tailed Student’s t-test was used to analyse differences
between two groups in figures showing cumulative data from
three independent experiments. Significance was P < 0.05.
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